Skip to content
10-K

Annual Report

Sigilon Therapeutics, Inc.

0001558370-23-003716

← back to feed
Filed
Mar 14, 2023 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 1, 2023 32.47M sh
Shares Diluted FY 2022 · Dec 31, 2022 32.41M sh
Shares Diluted FY 2022 · Dec 31, 2021 31.86M sh
Capex FY 2022 · Dec 31, 2022 $537K
Capex FY 2022 · Dec 31, 2021 $1.83M
Operating Cash Flow FY 2022 · Dec 31, 2022 −$51.47M
Operating Cash Flow FY 2022 · Dec 31, 2021 −$78.41M
Long Term Debt FY 2022 · Dec 31, 2022 $12.02M
Long Term Debt FY 2022 · Dec 31, 2021 $18.41M
Short Term Debt FY 2022 · Dec 31, 2022 $6.67M
Short Term Debt FY 2022 · Dec 31, 2021 $1.67M
Cash And Equivalents FY 2022 · Dec 31, 2022 $42.07M
Cash And Equivalents FY 2022 · Dec 31, 2021 $107.14M
Stockholders Equity FY 2022 · Dec 31, 2022 $39.14M
Stockholders Equity FY 2022 · Dec 31, 2021 $77.16M
Stockholders Equity FY 2022 · Dec 31, 2020 $146.16M
Current Liabilities FY 2022 · Dec 31, 2022 $30.99M
Current Liabilities FY 2022 · Dec 31, 2021 $34.89M
Total Liabilities FY 2022 · Dec 31, 2022 $48.14M
Total Liabilities FY 2022 · Dec 31, 2021 $67.21M
Current Assets FY 2022 · Dec 31, 2022 $74.41M
Current Assets FY 2022 · Dec 31, 2021 $126.39M
Total Assets FY 2022 · Dec 31, 2022 $87.28M
Total Assets FY 2022 · Dec 31, 2021 $144.37M
Eps Diluted FY 2022 · Dec 31, 2022 −$1.34
Eps Diluted FY 2022 · Dec 31, 2021 −$2.43
Eps Basic FY 2022 · Dec 31, 2022 −$1.34
Eps Basic FY 2022 · Dec 31, 2021 −$2.43
Sga Expense FY 2022 · Dec 31, 2022 $18.98M
Sga Expense FY 2022 · Dec 31, 2021 $20.17M
Rd Expense FY 2022 · Dec 31, 2022 $37.63M
Rd Expense FY 2022 · Dec 31, 2021 $65.07M
Net Income FY 2022 · Dec 31, 2022 −$43.56M
Net Income FY 2022 · Dec 31, 2021 −$77.31M
Operating Income FY 2022 · Dec 31, 2022 −$43.67M
Operating Income FY 2022 · Dec 31, 2021 −$75.64M
Revenue FY 2022 · Dec 31, 2022 $12.94M
Revenue FY 2022 · Dec 31, 2021 $9.6M